glp 1 injections for weight loss GLP-1 | Gulfport, MS GLP-1 INJECTIONS OR TABLETS |

Semaglutide (Wegovy) recently became the first GLP-1 approved by the FDA to treat adults with MASH with moderate-to-advanced fibrosis, based on the phase 3 ESSENCE trial

Translational perspective

2013;369:145-154) found that intensive lifestyle intervention focused on weight loss did not reduce cardiovascular events in a large cohort of adults with overweight/obesity and type 2 diabetes

Most plans place Wegovy on Tier 3 with 30-40% coinsurance, resulting in $380 to $540 monthly costs

This presents as acute painful neuropathy following substantial A1c reduction and typically improves over time

For tirzepatide, perhaps 0.5-1.25 mg instead of 2.5 mg